Adverse drug reactions to thalidomide in patients with Hansen's Disease

Trial Profile

Adverse drug reactions to thalidomide in patients with Hansen's Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Thalidomide (Primary)
  • Indications Erythema nodosum; Leprosy
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Sep 2017 New trial record
    • 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top